Absolutely no credibility...
Will they then lower their price targets tomorrow? No, they'll probably say "the weakness is a buying opportunity." Analysts have zero credibility. Cramer and CNBC guests have even less. Who would buy Twitter after this 28% short covering run up? Not even Mom and Pop in Peoria is that stupid.....
It's unreal....they're all "fair weather" analysts...If a stock goes up, they raise the PPS targets. It's all about competing for investment banking business. There's absolutely no credibility on Wall street.
It's nothing more than a game.....raising guidance is very subjective, i.e. they have no idea whether or not they can achieve those numbers. The poster above is correct, this move is very excessive, and was nothing more than a huge short covering rally. Let's see where the stock trades in another few weeks.
The implication here was that since Twitter had a better quarter with low expectations, Yelp will rally as well, which is why you saw a lot of short covering in AH today with the Twitter report. I'm short as well. It's all a game....the game is the analyst's numbers....if those numbers are exceeded, the stock could rally. The bigger issue in my opinion is the overall market, i.e. the fact that we're long overdue for a correction, or worse.
Yelp rallied last month after Priceline bought out Open Table, or I should say overpaid for Open Table. So everyone thought Yelp was the next acquisition. I don't think the company is in play, and neither does the market, as most of that move was faded and disappeared. I think any gap up will be faded tomorrow, and a lot will depend on the Fed talk and the broader market.
Let's see how it goes.....
It certainly is now, with this "me too" move in after hours. Yelp is not Twitter. Twitter is grossly overvalued with this short squeeze, and Yelp is not profitable, and doesn't have the leverage and scale opportunity that TWTR, FB, and LNKD have.
The talk will be how grossly overvalued the stock is, because of the short squeeze in AH. I wouldn't be surprised to see it reverse into the mid $40's.
Impressive growth drivers, this report was a one off cost related quarter, they expect a return to stellar growth going forward.
I say that, because I bought under $60 in AH, and I'm trying to enhance my trade....Oh, and I also think it will trade higher because shorts will cover after the gap down.
She says the valuations are stretched. What, so now we have the Federal reserve telling the market what to buy and what to sell? Raise your hand if you think the government is way out of hand, and esp. the power of the Fed.
Reviews are not a guarantee of profits....Don't confuse the two.
This happened very quickly. $56.31 a share value in the transaction.....I'm not greedy, I'll take it.....Great day so far!
1. Very positive efficacy results from their lead drug
2. Insider buying continues
3. Partnership with Celgene validates the science
I'm in today after the early am sell off.....This stock will trade over $50 by late August, IMHO.
Just being honest, it may be worth a trade. But unless it recovers by tomorrow (close the week near or over $72), the weekly chart is problematic at this point.
Shorts are using the broad market weakness to force the price down, so they can cover at lower prices. There's nothing weird, or wrong. It will be up later this week.
Siegel is a shill for CNBC......He's promoting his books....and CNBC is trying to promote their ratings.....The only thing that will drop this market now is a black swan, and I'm not even sure that will do it, CNBC and others will say it's a buying opportunity.
Which will probably be next week at this rate. Maybe this earnings season will start the correction, who knows.
ETF's.....It's been driving the market higher for the past few years.....